Total Debt Summary of GenMont Biotech Incorporation

GenMont Biotech Incorporation's latest annual total debt in 2023 was 58.3 Million TWD , up 68.79% from previous year.
GenMont Biotech Incorporation's latest quarterly total debt in 2024 Q1 was 100.68 Million TWD , up 72.68% from previous quarter.
GenMont Biotech Incorporation reported annual total debt of 34.54 Million TWD in 2022, up 5.54% from previous year.
GenMont Biotech Incorporation reported annual total debt of 32.73 Million TWD in 2021, down -4.65% from previous year.
GenMont Biotech Incorporation reported quarterly total debt of 109.69 Million TWD for 2024 Q2, up 8.95% from previous quarter.
GenMont Biotech Incorporation reported quarterly total debt of 58.3 Million TWD for 2023 Q4, up 1.21% from previous quarter.

Annual Total Debt Chart of GenMont Biotech Incorporation (2023 - 2009)

Historical Annual Total Debt of GenMont Biotech Incorporation (2023 - 2009)

Year	Total Debt	Total Debt Growth
2023	58.3 Million TWD	68.79%
2022	34.54 Million TWD	5.54%
2021	32.73 Million TWD	-4.65%
2020	34.33 Million TWD	5.14%
2019	32.65 Million TWD	17361.5%
2018	187 Thousand TWD	-86.28%
2017	1.36 Million TWD	-2.22%
2016	1.39 Million TWD	-61.37%
2015	3.6 Million TWD	-77.32%
2014	15.91 Million TWD	-96.32%
2013	432.55 Million TWD	-12.31%
2012	493.25 Million TWD	1.54%
2011	485.77 Million TWD	15137.48%
2010	3.18 Million TWD	91.47%
2009	1.66 Million TWD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	100.68 Million TWD	72.68%
2024 Q2	109.69 Million TWD	8.95%
2023 Q4	58.3 Million TWD	1.21%
2023 FY	58.3 Million TWD	68.79%
2023 Q2	35.26 Million TWD	2.48%
2023 Q3	57.61 Million TWD	63.38%
2023 Q1	34.4 Million TWD	-0.39%
2022 Q1	22.36 Million TWD	-31.66%
2022 Q2	22.31 Million TWD	-0.23%
2022 FY	34.54 Million TWD	5.54%
2022 Q4	34.54 Million TWD	59.73%
2022 Q3	21.62 Million TWD	-3.09%
2021 FY	32.73 Million TWD	-4.65%
2021 Q1	33.91 Million TWD	-1.22%
2021 Q2	33.37 Million TWD	-1.57%
2021 Q3	33.05 Million TWD	-0.97%
2021 Q4	32.73 Million TWD	-0.98%
2020 Q2	33.03 Million TWD	-1.48%
2020 Q3	34.81 Million TWD	5.4%
2020 Q4	34.33 Million TWD	-1.4%
2020 Q1	33.53 Million TWD	2.69%
2020 FY	34.33 Million TWD	5.14%
2019 Q1	34.14 Million TWD	18157.75%
2019 Q3	33.12 Million TWD	-1.57%
2019 Q4	32.65 Million TWD	-1.43%
2019 FY	32.65 Million TWD	17361.5%
2019 Q2	33.65 Million TWD	-1.42%
2018 Q2	- TWD	-100.0%
2018 Q4	187 Thousand TWD	523.33%
2018 FY	187 Thousand TWD	-86.28%
2018 Q1	1.51 Million TWD	11.01%
2018 Q3	30 Thousand TWD	0.0%
2017 Q2	1.58 Million TWD	11.29%
2017 FY	1.36 Million TWD	-2.22%
2017 Q4	1.36 Million TWD	24.7%
2017 Q3	1.09 Million TWD	-31.13%
2017 Q1	1.42 Million TWD	2.3%
2016 Q1	1.53 Million TWD	-57.36%
2016 Q2	2.45 Million TWD	59.58%
2016 Q3	1.51 Million TWD	-38.27%
2016 Q4	1.39 Million TWD	-8.05%
2016 FY	1.39 Million TWD	-61.37%
2015 Q1	18.15 Million TWD	14.08%
2015 Q3	3.63 Million TWD	-2.99%
2015 Q2	3.74 Million TWD	-79.38%
2015 FY	3.6 Million TWD	-77.32%
2015 Q4	3.6 Million TWD	-0.61%
2014 Q4	15.91 Million TWD	-97.08%
2014 FY	15.91 Million TWD	-96.32%
2014 Q2	540.36 Million TWD	-4.89%
2014 Q3	544.67 Million TWD	0.8%
2014 Q1	568.16 Million TWD	31.35%
2013 Q2	727 Thousand TWD	-61.29%
2013 Q3	430.93 Million TWD	59175.1%
2013 Q4	432.55 Million TWD	0.38%
2013 FY	432.55 Million TWD	-12.31%
2013 Q1	1.87 Million TWD	-99.62%
2012 Q4	493.25 Million TWD	-1.71%
2012 Q3	501.82 Million TWD	1.83%
2012 Q2	492.8 Million TWD	18267.69%
2012 Q1	2.68 Million TWD	-99.45%
2012 FY	493.25 Million TWD	1.54%
2011 Q1	480.22 Million TWD	14963.49%
2011 Q2	482.54 Million TWD	0.48%
2011 Q3	485.55 Million TWD	0.62%
2011 Q4	485.77 Million TWD	0.04%
2011 FY	485.77 Million TWD	15137.48%
2010 FY	3.18 Million TWD	91.47%
2010 Q4	3.18 Million TWD	0.0%
2009 FY	1.66 Million TWD	0.0%

Peer Total Debt Comparison of GenMont Biotech Incorporation

Name	Total Debt	Total Debt Difference
Apex Biotechnology Corp.	180.83 Million TWD	67.756%
Sinphar Pharmaceutical Co.,Ltd.	1.94 Billion TWD	97.002%
Panion & Bf Biotech Inc.	727.83 Million TWD	91.989%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	1.2 Billion TWD	95.178%
Abnova (Taiwan) Corporation	7.7 Million TWD	-656.644%
Adimmune Corporation	3.14 Billion TWD	98.145%
Tanvex BioPharma, Inc.	1.73 Billion TWD	96.633%
Polaris Group	1.19 Billion TWD	95.133%
Energenesis Biomedical CO.,LTD.	- TWD	-Infinity%
UnicoCell Biomed Co., Ltd.	74.32 Million TWD	21.554%
PELL Bio-Med Technology Co. Ltd.	172.55 Million TWD	66.21%

Global Stocks Search

GenMont Biotech Incorporation (3164.TW)

Total Debt Summary of GenMont Biotech Incorporation

Annual Total Debt Chart of GenMont Biotech Incorporation (2023 - 2009)

Historical Annual Total Debt of GenMont Biotech Incorporation (2023 - 2009)

Peer Total Debt Comparison of GenMont Biotech Incorporation